UM  > 中華醫藥研究院
Nanocarriers for TRAIL delivery: driving TRAIL back on track for cancer therapy
Wu, Xu1; Wang, Shengpeng2; Li, Mingxing1; Wang, Anqi2; Zhou, Yangyang2; Li, Peng2; Wang, Yitao2
Source PublicationNANOSCALE

Since its initial identification, tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) has been shown to be capable of selectively inducing apoptosis in cancer cells. However, translation of the encouraging preclinical studies of this cytokine into the clinic has been restricted by its extremely short half-life, the presence of resistant cancer cell populations, and its inefficient in vivo delivery. Recently, there has been exceptional progress in developing novel formulations to increase the circulatory half-life of TRAIL and new combinations to treat cancers that are resistant to TRAIL. In particular, TRAIL-based nanotherapies offer the potential to improve the stability of TRAIL and prolong its half-life in plasma, to specifically deliver TRAIL to a particular target site, and to overcome resistance to TRAIL. The aim of this review is to provide an overview of the state-of-the art drug delivery systems that are currently being tested or developed to improve the biological attributes of TRAIL-based therapies.

URLView the original
Indexed BySCI
WOS Research AreaChemistry ; Science & Technology - Other Topics ; Materials Science ; Physics
WOS SubjectChemistry, Multidisciplinary ; Nanoscience & Nanotechnology ; Materials Science, Multidisciplinary ; Physics, Applied
WOS IDWOS:000411862400003
The Source to ArticleWOS
Fulltext Access
Citation statistics
Cited Times [WOS]:18   [WOS Record]     [Related Records in WOS]
Document TypeJournal article
CollectionInstitute of Chinese Medical Sciences
Corresponding AuthorLi, Peng; Wang, Yitao
Affiliation1.Laboratory of Molecular Pharmacology, Department of Pharmacology, School of Pharmacy, Southwest Medical University, Luzhou, China
2.State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macao, China
Corresponding Author AffilicationInstitute of Chinese Medical Sciences
Recommended Citation
GB/T 7714
Wu, Xu,Wang, Shengpeng,Li, Mingxing,et al. Nanocarriers for TRAIL delivery: driving TRAIL back on track for cancer therapy[J]. NANOSCALE,2017,9(37):13879-13904.
APA Wu, Xu.,Wang, Shengpeng.,Li, Mingxing.,Wang, Anqi.,Zhou, Yangyang.,...&Wang, Yitao.(2017).Nanocarriers for TRAIL delivery: driving TRAIL back on track for cancer therapy.NANOSCALE,9(37),13879-13904.
MLA Wu, Xu,et al."Nanocarriers for TRAIL delivery: driving TRAIL back on track for cancer therapy".NANOSCALE 9.37(2017):13879-13904.
Files in This Item:
There are no files associated with this item.
Related Services
Recommend this item
Usage statistics
Export to Endnote
Google Scholar
Similar articles in Google Scholar
[Wu, Xu]'s Articles
[Wang, Shengpeng]'s Articles
[Li, Mingxing]'s Articles
Baidu academic
Similar articles in Baidu academic
[Wu, Xu]'s Articles
[Wang, Shengpeng]'s Articles
[Li, Mingxing]'s Articles
Bing Scholar
Similar articles in Bing Scholar
[Wu, Xu]'s Articles
[Wang, Shengpeng]'s Articles
[Li, Mingxing]'s Articles
Terms of Use
No data!
Social Bookmark/Share
All comments (0)
No comment.

Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.